155 related articles for article (PubMed ID: 36934829)
1. Fed intestinal solubility limits and distributions applied to the Developability classification system.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 May; 186():74-84. PubMed ID: 36934829
[TBL] [Abstract][Full Text] [Related]
2. Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jan; 170():160-169. PubMed ID: 34923138
[TBL] [Abstract][Full Text] [Related]
3. Structured solubility behaviour in fed simulated intestinal fluids.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 Dec; 193():58-73. PubMed ID: 37890541
[TBL] [Abstract][Full Text] [Related]
4. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jul; 176():108-121. PubMed ID: 35605926
[TBL] [Abstract][Full Text] [Related]
5. Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid.
Inês Silva M; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2022 Aug; 177():126-134. PubMed ID: 35718078
[TBL] [Abstract][Full Text] [Related]
6. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
Abuhassan Q; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2021 Nov; 168():90-96. PubMed ID: 34419602
[TBL] [Abstract][Full Text] [Related]
7. Multidimensional analysis of human intestinal fluid composition.
Pyper K; Brouwers J; Augustijns P; Khadra I; Dunn C; Wilson CG; Halbert GW
Eur J Pharm Biopharm; 2020 Aug; 153():226-240. PubMed ID: 32585351
[TBL] [Abstract][Full Text] [Related]
8. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.
Perrier J; Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert G
Eur J Pharm Sci; 2018 Jan; 111():247-256. PubMed ID: 28987539
[TBL] [Abstract][Full Text] [Related]
9. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
[TBL] [Abstract][Full Text] [Related]
10. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.
Ainousah BE; Perrier J; Dunn C; Khadra I; Wilson CG; Halbert G
Mol Pharm; 2017 Dec; 14(12):4170-4180. PubMed ID: 29072917
[TBL] [Abstract][Full Text] [Related]
11. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
12. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
Khadra I; Zhou Z; Dunn C; Wilson CG; Halbert G
Eur J Pharm Sci; 2015 Jan; 67():65-75. PubMed ID: 25444845
[TBL] [Abstract][Full Text] [Related]
13. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
14. A Refined Developability Classification System.
Rosenberger J; Butler J; Dressman J
J Pharm Sci; 2018 Aug; 107(8):2020-2032. PubMed ID: 29665381
[TBL] [Abstract][Full Text] [Related]
15. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
Jamil R; Polli JE
Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
[TBL] [Abstract][Full Text] [Related]
16. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
[TBL] [Abstract][Full Text] [Related]
17. Excipient Impact on Fenofibrate Equilibrium Solubility in Fasted and Fed Simulated Intestinal Fluids Assessed Using a Design of Experiment Protocol.
Ainousah BE; Khadra I; Halbert GW
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896244
[TBL] [Abstract][Full Text] [Related]
18. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
19. Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
Batchelor HK; Kendall R; Desset-Brethes S; Alex R; Ernest TB;
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):833-42. PubMed ID: 23665448
[TBL] [Abstract][Full Text] [Related]
20. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
Zaki NM; Artursson P; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
